Inequality and Human Genetics
By Richard Hayes,
The New York Times
| 09. 16. 2008
[Letter to the editor]
David Frum correctly acknowledges that income inequality in the United States has been growing steadily and that the use of genetic technology by the affluent to enhance the "intelligence, health, beauty and strength" of their offspring would exacerbate this trend. But his suggestion that this challenge could be addressed by somehow ensuring that all have access to such technology is woefully misguided. The advent of these technologies would spark a techno-eugenic rat race impossible to constrain absent some system of authoritarian, allocative control. It would fundamentally change the way people regard their children and one another and undermine the integrity of the common human nature that sustains all human values, beliefs and institutions. The genetic modification of our children is a practice that conservatives and liberals alike should be able to agree poses far more risks than benefits, and should be taken off the table as an option.
Richard Hayes
Executive Director
Center for Genetics and Society
Oakland, Calif.
Related Articles
By Yelena Biberman and Jonathan D. Moreno, Bioethics Forum | 04.16.2024
A quiet biological revolution in warfare is underway. The genome is emerging as a new domain of conflict. The level of destruction that only nuclear weapons could previously achieve is fast becoming as accessible as a cyberattack.
Now for the...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...